갑상선암 수술 후 유착방지제(Guardix-SG<sup>Ⓡ</sup>) 사용과 배액량과의 관계
Anti-adhesive Agent (Guardix-SG<sup>Ⓡ</sup>) Does Not Influence the Drainage Volume after Thyroid Cancer Surgery
- 대한내분비외과학회
- The Koreran journal of Endocrine Surgery
- 13권4호
-
2013.12251 - 256 (6 pages)
- 52
Purpose: This study was conducted to investigate whether the use of HA-CMC solution in thyroid surgery influences drainage amount and hospital stay. Methods: Between November 2012 and December 12, 147 patients with thyroid cancer who underwent total thyroidectomy with central compartment neck dissection were analyzed retrospectively. The patients were divided into four groups; those with or without HA-CMC solution application and high or low output drainage. Results: There were no differences in hospital stay and mean total drainage between the with and without HA-CMC solution application groups (P=0.230, P=0.732). The mean hospital stay was 2.2±0.4 days for the low output of drainage group and 3.1±0.6 days for the high output drainage group (P<0.001). There was no significant difference in the use of HA-CMC solution (41.1% vs. 56.8%, P=0.070). Conclusion: The use of HA-CMC solution in thyroid cancer surgery might not increase drainage amount and make hospital stay longer.
(0)
(0)